| Code | 6161A | ||||||||||
| MA number | 09/0262/13-S | ||||||||||
| Product Form: | cps end 100x40 mg (fľ.skl.hnedá-100 ml) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Zentiva, k.s., Czechia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.06.2013 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Helicid 40 cps end_03_2022.pdf
|
| SPC: |
SPC_Helicid 40_cps end_03_2022.pdf
|
| Safety feature | Yes |
| Data update: | 04.06.2018 |
